News
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Rottapharm | Madaus Acquires the Zyma® Brands; Plexus Ventures Facilitated the Deal
"Los Angeles, California -- Plexus Ventures is pleased to announce the successful completion of a recent divestment project. Plexus provided professional services to the seller in their divestment of the Zyma® Brands to Rottapharm | Madaus in 19 countries including...
Novartis Divests Optalidon to Omega Pharma
London, United Kingdom — Plexus Ventures is pleased to announce the conclusion of a successful divestment assignment for Novartis Consumer Health (Switzerland), for which Plexus Ventures acted as exclusive external advisor. Novartis recently sold the rights to...
Events
BIO International Convention - Boston
June 16 – 19, 2025
Click to Schedule a Meeting
CHPI - Frankfurt
October 28 – 30, 2025
Click to Schedule a Meeting
Articles
Nucleic acid delivery: Are you developing what Big Pharma seeks?
Apr 11, 2023
How can we help you?
Plexus Ventures assists with M&A, divestments, licensing, strategic advice and consulting.
Subscribe to
Plexus News
Follow Us
Check out Plexus Ventures and other industry news shared daily.